CClinicalTrials.gg
RecruitingNCT05739695Updated Feb 6, 2024

A Trial of Radial EBUS Versus VBN for the Peripheral Pulmonary Lesions

An interventional study of Virtual bronchoscopy navigation and radial EBUS in Lung Cancer, Tuberculosis and Pneumonia, sponsored by Ilya Sivokozov. Recruiting at 6 sites in Russian Federation. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-06.

Sponsored by Ilya Sivokozov · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Feb 2022; still recruiting 4 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Peripheral pulmonary lesions are of growing importance in respiratory field. Early detection of lung cancer, tuberculosis and other diseases often needs a bronchoscopic investigation with different types of navigation. Current randomized clinical study is intended to compare three different modalities of navigation in bronchial tree - virtual bronchoscopy (VBN), radial endobronchial ultrasound (EBUS) and combination of both techniques.

Read the detailed description

Current randomized clinical study is intended to compare three different modalities of navigation in bronchial tree - virtual bronchoscopy, radial EBUS and combination of both techniques. Around 300 patients with incidentally detected peripheral pulmonary lesions will be enrolled in 9 centers among Russia. All patients after obtaining an informed consent will be randomized in 1:1:1 fashion to three study groups depending on type of navigation technique used. All patients will undergone navigational bronchoscopy with rEBUS (group A), VBN (group B) and rEBUS+VBN (group C), data on diagnostic efficacy and safety of each modality of navigation will be analyzed.

02

Conditions studied

  • Lung Cancer
  • Tuberculosis
  • Pneumonia

Browse trials for

Keywords

  • navigation bronchoscopy
  • virtual bronchoscopy navigation
  • radial endobronchial ultrasound
  • BAL
  • TBLB
03

In context

Tuberculosis

1,417 studies on the registry are indexed under Tuberculosis; 208 are open to participants now.

This study's planned enrollment of 300 is above the median of 150 across 952 interventional studies indexed under Tuberculosis.

Browse Tuberculosis studies →

Lead sponsor

This is the only study on the registry with Ilya Sivokozov as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patients with newly diagnosed unverified solitary or multiple (up to 3) peripheral pulmonary lesions (PPLs)
  2. PPL size 5 - 40 mm
  3. Actual chest CT scan (\<31 days prior to navigation bronchoscopy), collimation 1 mm, pulmonary window, DICOM format
  4. Age > 18 years
  5. Signed Informed consent form
  6. Willing and ability to undergone a navigational bronchoscopy

Exclusion criteria

Exclusion Criteria:

  1. Unability to undergone navigation bronchoscopy for any reason
  2. Any malignant disease during last 36 months
  3. Known central endobronchial lesion of any cause
  4. HIV-infection
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    VBN

    Virtual bronchoscopy

    Diagnostic Test: Virtual bronchoscopy navigation

  • Experimental
    VBN+rEBUS

    Combination of VBN and radial EBUS

    Diagnostic Test: Virtual bronchoscopy navigation · Diagnostic Test: radial EBUS

  • Active comparator
    rEBUS

    Radial EBUS as a gold standard

    Diagnostic Test: radial EBUS

Interventions

  • Diagnostic testVirtual bronchoscopy navigation

    It is planned to use VBN as the only navigation technique to compare it with rEBUS

  • Diagnostic testradial EBUS

    It is planned to use rEBUS as the only navigation technique to compare it with VBN

06

What researchers measure

Primary outcomes

  1. Diagnostic Efficacy of navigational bronchoscopy in each study arm

    Incidence of final diagnoses confirmed by navigational bronchoscopy for each study arm

    Time frame: At the end of study enrollment

Secondary outcomes

  1. Efficacy of each endoscopic biopsy modality in confirmation of final diagnosis

    Incidence of final diagnoses confirmed by navigational bronchoscopy for bronchoalveolar lavage, brush and transbronchial lung biopsy separately

    Time frame: At the end of study enrollment

Other outcomes

  1. Safety profile of each study arm

    Incidence of complications reported at each study arm procedures

    Time frame: At the end of study enrollment

07

Study locations

6 of 6 sites recruiting
  • Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
    Chelyabinsk, Russian Federation
    • Konstantin Kulaev, Md PhD · Contact
    Recruiting
  • Kurgan Regional Oncological Dispensary
    Kurgan, Russian Federation
    • Yulia Verkhodlib, MD · Contact
    Recruiting
  • Central TB Research Institute
    Moscow, Russian Federation
    • Ilya Sivokozov, MD PhD · Contact · sivokozov@bronchology.ru
    • Irina Shabalina, MD PhD · Contact
    • Yana Chesalina, MD · Sub investigator
    Recruiting
  • P. Hertsen Moscow Oncology Research Institute
    Moscow, Russian Federation
    • Alexander Vodoleev, MD PhD · Contact
    Recruiting
  • National Medical Research Centre for Oncology
    Rostov-on-Don, Russian Federation
    • Vadislav Legostaev, MD PhD · Contact
    Recruiting
  • Tomsk Regional Oncological Dispensary
    Tomsk, Russian Federation
    • Natalya Li, MD · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05739695
Lead sponsor
Ilya Sivokozov
Responsible party
Ilya Sivokozov (Head of Respiratory Endoscopy Department, Central TB Research Institute) — Sponsor-investigator
First posted
Feb 22, 2023
Start date
Feb 1, 2022
Primary completion
Dec 1, 2024 (estimated)
Completion
Mar 1, 2025 (estimated)
Last update
Feb 6, 2024

Study contacts

Ilya Sivokozov, MD PhD
Contact
sivokozov@bronchology.ru
+79670457905
Ilya Sivokozov, MD PhD
study chair · Central TB Research Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion